BIOXYTRAN, INC
Data quality: 83%
BIXT
OTC
Manufacturing
Chemicals
$0.04
▼
$0.00
(-2.63%)
Mkt Cap: 4.50 M
Price
$0.04
Mkt Cap
4.50 M
Day Range
$0.04 — $0.04
52-Week Range
$0.03 — $0.20
Volume
89,500
Open $0.04
50D / 200D Avg
$0.04
15.53% below
50D / 200D Avg
$0.07
46.06% below
Quick Summary
Key Takeaways
Negative free cash flow of -247,174.0
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.00
Interest Coverage-9.44
Valuation
PE (TTM)
-2.13
Below sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -2.1 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.5 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -2.11 M |
| ROE | N/A | ROA | -1391.19% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -247,174.0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.00 |
| Interest Coverage | -9.44 | Asset Turnover | N/A |
| Working Capital | -3.05 M | Tangible Book Value | -3.05 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.13 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -5.49% | ||
| Market Cap | 4.50 M | Enterprise Value | 4.50 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.03 | Revenue / Share | N/A |
| FCF / Share | 0.00 | OCF / Share | 0.00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 11.70% |
| SBC-Adj. FCF | -255,590 | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -2.37 M | -4.28 M | -2.46 M | -4.53 M | -2.54 M |
| EPS (Diluted) | -0.02 | -0.03 | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -2.22 M | -3.82 M | -2.13 M | -4.21 M | -1.27 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 112,337.0 | 1.15 M | 977,768.0 | 2.01 M | 544,519.0 |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 84,240.0 | — | 2.02 M | 236,577.0 | 1.01 M |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 138,694.0 | 137,638.0 | 370,936.0 | 119,290.0 | 326,403.0 |
| Total Liabilities | 1.93 M | 3.25 M | 3.66 M | 3.28 M | 2.27 M |
| Shareholders' Equity | -1.79 M | -3.11 M | -3.29 M | -3.16 M | -1.94 M |
| Total Debt | 48,000.0 | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — |
| Current Assets | 5,154.0 | 26,086.0 | 295,401.0 | 72,358.0 | 316,403.0 |
| Current Liabilities | 1.93 M | 3.25 M | 3.66 M | 3.28 M | 2.27 M |
{"event":"ticker_viewed","properties":{"ticker":"BIXT","listing_kind":"stock","pathname":"/stocks/bixt","exchange":"OTC","country":"US"}}